Alkyl Amines Chemicals Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 3 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹9.9K Cr

Alkyl Amines expects double-digit volume growth in FY ‘25, targeting around 10% to 15%, consistent with recent trends. The company expects double-digit volume growth of around 10% to 15% in FY 2025, consistent with past achievements.

From Alkyl Amines Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

2,053

Market Cap

₹9.9K Cr

P/E Ratio

44.1

How does Alkyl Amines Chemicals Ltd rank in Chemicals & Petrochemicals?

Compare Alkyl Amines Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Alkyl Amines Chemicals Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹387 Cr, net profit ₹45 Cr.

Full financials →

📊 Revenue & Sales Performance

  • Alkyl Amines expects double-digit volume growth in FY ‘25, targeting around 10% to 15%, consistent with recent trends.
  • The company remains optimistic about future growth, driven by increasing demand from its growing customer base and large market opportunity in India.
  • Volume growth is expected to be sustained over the next two years.
  • Pricing pressure is anticipated to continue, especially in ethylamines and methylamines, due to oversupply.
  • Sales/revenue growth is expected to be impacted by price pressures, although volume gains and raw material cost reductions may partially offset this.
  • New product launches are planned with mechanical completion of CAPEX at Dahej by December 2025/January 2026, which will contribute to growth from next fiscal year onwards.
  • Despite near-term market challenges, the company is cautiously optimistic and gearing for long-term growth opportunities.

📈 Profitability & Margins

  • The company expects double-digit volume growth of around 10% to 15% in FY 2025, consistent with past achievements.
  • Pricing pressure on products like methylamines and ethylamines is likely to persist, making it difficult to predict price movements in the near term.
  • EBITDA margins are expected to remain stable around 20-21%, with no clear expectation of improvement due to ongoing pricing pressures.
  • New product launches from ongoing CAPEX at Dahej (expected mechanical completion by Dec 2025/Jan 2026) may positively impact revenues in FY 2026.
  • The company maintains a cautiously optimistic outlook, supported by growing customer demand and a large domestic market opportunity.
  • Anti-dumping duties and capacity expansions could impact realizations but are being closely monitored.

🏗️ Capital Expenditure Plans

  • Ongoing CAPEX of approximately Rs. 110-120 crores focused on new product development at the Dahej site.
  • Mechanical completion of the new product plant expected by December 2025 or January 2026.
  • Additional CAPEX projects are in the pipeline, but timelines and amounts are yet to be finalized.
  • No change in announced CAPEX plans; continuing as per schedule.
  • Total carry-forward projects and new projects forecasted around Rs. 150 crores for the next year, including around Rs. 100 crores at Dahej.
  • Future strategic investments will be announced when ready.

💰 Fundraising & Capital Structure

  • There is no specific mention of any current or planned fundraising through debt or equity in the transcript.
  • The company is focusing on ongoing CAPEX projects, including around Rs. 150 crores of forecasted CAPEX for the next year, with Rs. 100 crores allocated for the Dahej site.
  • There is no indication from management about raising funds through equity or debt.
  • Promoter group buying shares from the open market was noted, but no buyback or other shareholder rewards were announced.
  • Overall, no announcements or guidance related to future or current fundraising via debt or equity were provided in the earnings call.

📋 Order Book & Pipeline

  • The company mentioned a carry forward of projects from the past year and some new projects in the current year, totaling around Rs. 150 crores forecasted for next year.
  • Out of this Rs. 150 crores, approximately Rs. 100 crores pertains to ongoing project expenditure at the Dahej site.
  • The Dahej site project is expected to achieve mechanical completion by December 2025 or early January 2026.
  • Additional projects are in the pipeline, but timelines and amounts are yet to be finalized and will be announced when ready.

Key Metrics

Frequently Asked Questions

What were Alkyl Amines Chemicals Ltd Q4 FY25 results?

Alkyl Amines expects double-digit volume growth in FY ‘25, targeting around 10% to 15%, consistent with recent trends. The company expects double-digit volume growth of around 10% to 15% in FY 2025, consistent with past achievements.

What is Alkyl Amines Chemicals Ltd share price analysis?

Alkyl Amines Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 44.1 with a market cap of ₹9,921 Cr. Investors should review the full earnings analysis for detailed insights.

Is Alkyl Amines Chemicals Ltd planning capital expenditure?

Ongoing CAPEX of approximately Rs.

Keep Alkyl Amines Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Alkyl Amines's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • PCBL Chemical (Q4 FY25)

    Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

  • Fine Organic (Q4 FY25)

    Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Key concall takeaways from Fine Organic Industries Ltd's Q4…

  • Galaxy Surfact. (Q4 FY25)

    Organic growth capital allocation of 50%-60% of operating cash flows to fuel expansion. Key concall takeaways from Galaxy Surfactants Ltd's Q4 FY25 earnings…

  • Indian Emuls (Q4 FY25)

    Focus on niche and higher-margin products alongside expansion in direct sales (currently 50-60% direct sales). Key concall takeaways from Indian Emulsifiers…